ENZYMATICA AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3 SEK | 0.00% |
|
-2.60% | -23.95% |
| 25/04 | Enzymatica AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 27/03 | Enzymatica AB Announces Composition of Nomination Committee | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 49.78M | - | - | ||||
| 750B | ||||||
| 606B | ||||||
| 356B | ||||||
| 326B | ||||||
| 286B |
- Stock Market
- Equities
- ENZY Stock
- Charts Enzymatica AB
- Sector Chart
